Report Materials
EXECUTIVE SUMMARY:
This audit was conducted by the New York State Office of the State Comptroller (OSC) as part of our continuing partnership efforts with State auditors to expand audit coverage of the Medicaid program. The objective of the review was to determine whether the New York State Department of Health (Health) had maximized Medicaid Drug Rebate Program (Program) revenues owed to Medicaid. The OSC found that Health had not maximized Program revenues; had not properly tracked or pursued rebate revenues; and had essentially relied on drug manufacturers to remit the rebates they owed. As a result, Health had not recouped between approximately $14 million to $20 million it should have collected during the OSC audit period. The OSC also concluded that, for all practical purposes, Health did not have a functioning accounting system for the Program. The OSC recommended financial adjustments and procedural corrections agreed to by Department of Health officials.
Notice
This report may be subject to section 5274 of the National Defense Authorization Act Fiscal Year 2023, 117 Pub. L. 263.